Author:
Markopoulos Anastasios K.,Michailidou Evangelia Z.,Tzimagiorgis Georgios
Abstract
Oral cancer refers to all malignancies that arise in the oral cavity, lips and pharynx, with 90% of all oral cancers being oral squamous cell carcinoma. Despite the recent treatment advances, oral cancer is reported as having one of the highest mortality ratios amongst other malignancies and this can much be attributed to the late diagnosis of the disease. Saliva has long been tested as a valuable tool for drug monitoring and the diagnosis systemic diseases among which oral cancer. The new emerging technologies in molecular biology have enabled the discovery of new molecular markers (DNA, RNA and protein markers) for oral cancer diagnosis and surveillance which are discussed in the current review.
Publisher
Bentham Science Publishers Ltd.
Reference113 articles.
1. The international statistical classification of diseases and related health problems 1 In: World Health Organization; Geneva. 1992. (10 )
2. American Cancer Society. Cancer Facts and Figures 2007. Atlanta: American Cancer Society 2007.
3. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000, cancer incidence, mortality and prevalence worldwide, Version 10. Lyon: IARC Press 2001.
4. Peacock S, Pogrel A, Schmidt BL. Exploring the reasons for delay in treatment of oral cancer Am Dent Assoc 2008; 139 : 1346-52.
5. Schantz SP. Biologic markers, cellular differentiation, and metastatic head and neck cancer Eur Arch Otorhinolaryngol 1993; 250 : 424-8.
Cited by
70 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献